Tops & Flops Stocks
| Security | Change (%) | 1w | 1m | 1y | YTD ▲ | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Icon plc | 0.070% | -4.718% | -1.501% | 26.224% | 11.721% | - | - |
| Novartis AG ADR | 0.490% | 4.508% | 2.410% | 7.822% | 11.842% | 31.443% | 21.893% |
| Merck KGaA | 2.570% | 7.918% | 4.328% | 0.717% | 12.192% | -6.728% | 71.262% |
| Chugai Pharmaceutical Co Ltd | -0.740% | 9.026% | 12.786% | 39.449% | 12.219% | 18.236% | - |
| TG Therapeutics Inc. | -0.240% | -7.276% | 8.738% | 1.034% | 12.516% | -41.502% | - |
| Oramed Pharmaceuticals | -4.340% | 1.663% | -0.459% | -20.000% | 12.665% | -79.519% | -27.954% |
| Fagron N.V. | 0.210% | 0.965% | 3.289% | 16.873% | 12.679% | 8.463% | - |
| Genfit S.A. | 1.850% | -2.980% | 10.298% | 16.619% | 12.899% | 26.319% | -74.241% |
| Almirall S.A. | 0.310% | 5.104% | 1.645% | 10.438% | 13.046% | -27.681% | - |
| Neurocrine Bioscience | 0.630% | 2.116% | 5.134% | 46.361% | 13.286% | 61.508% | 72.385% |
| Celldex Therapeutics | 0.990% | 21.893% | 19.075% | 31.210% | 13.812% | 9.691% | 675.895% |
| Viatris Inc. | 0.000% | 2.204% | 12.085% | 18.028% | 14.130% | -7.374% | -33.552% |
| Intra-Cellular Therapies Inc. | 0.670% | 7.971% | 16.406% | 34.964% | 14.264% | 153.315% | 952.260% |
| Ani Pharmaceuticals Inc. | -0.870% | -1.724% | -3.390% | 19.247% | 14.458% | 105.036% | -25.451% |
| Innoviva Inc. | -0.600% | 5.096% | 11.486% | 41.026% | 15.385% | 50.000% | 64.244% |
| Organigram Holdings Inc. | 2.810% | -1.189% | 3.601% | 3.745% | 15.969% | -83.739% | -92.986% |
| Akebia Therapeutics Inc. | 2.120% | 8.540% | 44.912% | -5.424% | 16.041% | -36.449% | -64.835% |
| Roche Holding AG ADR | -0.410% | 4.012% | 15.163% | 7.138% | 16.089% | -6.191% | - |
| Active Biotech AB | - | 0.000% | 7.034% | -51.389% | 17.057% | -70.833% | -86.742% |
| Astrazeneca ADR | 2.080% | 0.000% | -2.041% | 10.769% | 17.073% | 50.000% | - |
| Merck & Co. Inc. | 1.390% | -0.173% | -1.199% | 19.585% | 17.157% | 74.743% | 57.007% |
| Collegium Pharmaceutical Inc | -0.620% | 9.524% | 8.054% | 62.626% | 17.518% | 56.311% | - |
| Aldeyra Therapeutics Inc. | 2.640% | 2.745% | 25.262% | -45.222% | 17.549% | -51.051% | - |
| Genomma Lab International | 2.960% | -0.571% | 4.819% | 8.750% | 17.568% | 2.353% | 7.780% |
| AstraZeneca plc | 2.750% | -0.759% | -1.406% | 10.871% | 17.676% | 50.450% | 86.053% |